157 related articles for article (PubMed ID: 29142995)
1. Screening of novel RGD peptides to modify nanoparticles for targeted cancer therapy.
Ge L; You X; Huang K; Kang Y; Chen Y; Zhu Y; Ren Y; Zhang Y; Wu J; Qian H
Biomater Sci; 2017 Dec; 6(1):125-135. PubMed ID: 29142995
[TBL] [Abstract][Full Text] [Related]
2. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
[TBL] [Abstract][Full Text] [Related]
4. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
5. Targeted Smart pH and Thermoresponsive N,O-Carboxymethyl Chitosan Conjugated Nanogels for Enhanced Therapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells.
Verma NK; Purohit MP; Equbal D; Dhiman N; Singh A; Kar AK; Shankar J; Tehlan S; Patnaik S
Bioconjug Chem; 2016 Nov; 27(11):2605-2619. PubMed ID: 27643823
[TBL] [Abstract][Full Text] [Related]
6. Comparison in docetaxel-loaded nanoparticles based on three different carboxymethyl chitosans.
Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
Int J Biol Macromol; 2017 Aug; 101():1012-1018. PubMed ID: 28389400
[TBL] [Abstract][Full Text] [Related]
7. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.
Naruphontjirakul P; Viravaidya-Pasuwat K
Int J Nanomedicine; 2019; 14():4105-4121. PubMed ID: 31239670
[No Abstract] [Full Text] [Related]
8. pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.
Wang Y; Qin F; Tan H; Zhang Y; Jiang M; Lu M; Yao X
Int J Nanomedicine; 2015; 10():7359-69. PubMed ID: 26677325
[TBL] [Abstract][Full Text] [Related]
9. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
Lin CC; Lin CW
Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of chitosan conjugated GGRGDSK peptides as a cancer cell-targeting molecular transporter.
El-Sayed NS; Shirazi AN; El-Meligy MG; El-Ziaty AK; Nagieb ZA; Parang K; Tiwari RK
Int J Biol Macromol; 2016 Jun; 87():611-22. PubMed ID: 26976071
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
12. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin.
Guo H; Zhang D; Li C; Jia L; Liu G; Hao L; Zheng D; Shen J; Li T; Guo Y; Zhang Q
Int J Pharm; 2013 Dec; 458(1):31-8. PubMed ID: 24140544
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of a novel potential carrier for a hydrophilic antitumor drug: Auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochloride.
Xiong W; Li L; Wang Y; Yu Y; Wang S; Gao Y; Liang Y; Zhang G; Pan W; Yang X
Int J Pharm; 2016 Sep; 511(1):267-275. PubMed ID: 27424168
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
15. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-triggered self-assembly of native amphiphilic peptides into spherical nanoparticles.
Fan X; Zhao F; Wang X; Wu G
Oncotarget; 2016 Sep; 7(36):58445-58458. PubMed ID: 27533248
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of self-assembled chitosan-dispersed LDL nanoparticles for drug delivery with a one-step green method.
Tian J; Xu S; Deng H; Song X; Li X; Chen J; Cao F; Li B
Int J Pharm; 2017 Jan; 517(1-2):25-34. PubMed ID: 27845214
[TBL] [Abstract][Full Text] [Related]
18. Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier.
Kamaraj S; Palanisamy UM; Kadhar Mohamed MSB; Gangasalam A; Maria GA; Kandasamy R
Eur J Pharm Sci; 2018 Apr; 116():48-60. PubMed ID: 29355595
[TBL] [Abstract][Full Text] [Related]
19. Peptide decorated calcium phosphate/carboxymethyl chitosan hybrid nanoparticles with improved drug delivery efficiency.
Wang J; Chen B; Zhao D; Peng Y; Zhuo RX; Cheng SX
Int J Pharm; 2013 Mar; 446(1-2):205-10. PubMed ID: 23422273
[TBL] [Abstract][Full Text] [Related]
20. Systematic investigation of fabrication conditions of nanocarrier based on carboxymethyl chitosan for sustained release of insulin.
Bai X; Kong M; Xia G; Bi S; Zhou Z; Feng C; Cheng X; Chen X
Int J Biol Macromol; 2017 Sep; 102():468-474. PubMed ID: 28366858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
